SGLT-2 inhibitors and risk of 59 long-term health conditions, hospitalization, and mortality

More on SGLT2 inhibitors

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026

• SGLT2 inhibitors raise genital but not urinary infection risk

  Clinical Pharmacology and Therapeutics · 4 Oct 2026

• GLP-1 agonists linked to lower dementia risk after COVID-19

  Drug Design, Development and Therapy · 5 Oct 2026

  

• Early statin use links to lower dementia risk in diabetes

  The Lancet Regional Health Europe · 4 Oct 2026